A
Autonomix Medical
D treatment of diseases involving the peripheral nervous system
About Autonomix Medical
Autonomix, Inc. is a pioneering medical device company dedicated to transforming the diagnosis and treatment of diseases involving the peripheral nervous system. The company operates in the medical technology sector, focusing on developing advanced tools that offer unprecedented sensitivity in detecting and differentiating peripheral neural signals. Autonomix's flagship technology is a catheter-based microchip sensing array, which boasts up to 1,000 times greater sensitivity than existing technologies. This innovation enables transvascular diagnosis and treatment of peripheral nervous system diseases virtually anywhere in the body, a significant leap forward in medical diagnostics and therapeutics.
The company primarily serves healthcare providers and medical institutions that treat conditions related to the peripheral nervous system. Initially, Autonomix is targeting the treatment of pancreatic cancer and pancreatitis, both of which can cause severe chronic pain and require effective solutions. By offering a more precise and sensitive diagnostic tool, Autonomix aims to improve patient outcomes and reduce the burden of these debilitating conditions.
Autonomix's business model revolves around the development, manufacturing, and sale of its proprietary medical devices. Revenue is generated through the direct sale of these devices to hospitals, clinics, and other healthcare facilities. Additionally, the company may explore partnerships and licensing agreements to expand the reach and application of its technology.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2024
News
Open roles
Autonomix Medical in the The Woodlands ecosystem
The Autonomix Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Lincoln Park Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Autonomix Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Autonomix Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

